Search - tctmd.com

Displaying 301 - 320 of 479

Sort: Relevancy | Date

News Conference News ESC 2019

MITRA-FR at 2 Years: Still No Benefit of MitraClip Over Meds

Shelley Wood

September 02, 2019

News Opinion Off Script

#Selfies, Carrots, and Push-ups: A Defense of Social Media in Modern-Day Medicine

Mamas Mamas, BMBCh

August 23, 2019

News Daily News

Protracted Opioid Use Not Uncommon After Cardiothoracic Surgery

Caitlin E. Cox

August 23, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

Late Follow-up of Surgical MV Repair: Insights for Timing, Innovation

Shelley Wood

August 20, 2019

News Daily News

Expert Consensus Gives Initial Guidance on Post-TAVR Conduction Disturbances

Yael L. Maxwell

August 20, 2019

News Daily News

No Volume-Outcome Link With Watchman for LAA Closure? Single-Center Study

Michael O'Riordan

August 19, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Daily News

Earlier Care, More Data Needed to Increase Treatment Success in Tricuspid Regurgitation

Yael L. Maxwell

August 07, 2019

News Features

Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?

Yael L. Maxwell

August 02, 2019

News Daily News

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Todd Neale

July 29, 2019

News Daily News

Machine Learning Helps Predict In-Hospital Mortality Post-TAVR, but Skepticism Abounds

Todd Neale

July 19, 2019

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Daily News

CMS Releases Final Decision Memo on Rules for TAVR Program Reimbursement

Shelley Wood

June 24, 2019

News Industry News

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

June 24, 2019

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

News Conference News TVT 2019

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Michael O'Riordan

June 14, 2019

News Conference News TVT 2019

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Shelley Wood

June 14, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

Advertisement

MITRA-FR at 2 Years: Still No Benefit of MitraClip Over Meds

#Selfies, Carrots, and Push-ups: A Defense of Social Media in Modern-Day Medicine

Protracted Opioid Use Not Uncommon After Cardiothoracic Surgery

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Late Follow-up of Surgical MV Repair: Insights for Timing, Innovation

Expert Consensus Gives Initial Guidance on Post-TAVR Conduction Disturbances

No Volume-Outcome Link With Watchman for LAA Closure? Single-Center Study

FDA Expands TAVR Indication to Low-Risk Patients

Earlier Care, More Data Needed to Increase Treatment Success in Tricuspid Regurgitation

Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Machine Learning Helps Predict In-Hospital Mortality Post-TAVR, but Skepticism Abounds

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

CMS Releases Final Decision Memo on Rules for TAVR Program Reimbursement

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content